21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013

The purpose of this study was to determine if receipt of chemotherapy was associated with utilization of the 21-gene recurrence score assay (RS assay) or with recurrence score (RS) in eligible patients. Using the National Cancer Data Base (NCDB), we identified female patients eligible for RS assay b...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Breast Cancer Res Treat
Hoofdauteurs: Parsons, Benjamin M., Landercasper, Jeffrey, Smith, Angela L., Go, Ronald S., Borgert, Andrew J., Dietrich, Leah L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer US 2016
Onderwerpen:
Epidemiology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5012154/
https://ncbi.nlm.nih.gov/pubmed/27507245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3926-5
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items